FDAnews
www.fdanews.com/articles/130800-otsuka-phase-iii-trial-meets-efficacy-criteria

Otsuka: Phase III Trial Meets Efficacy Criteria

October 5, 2010
Otsuka Pharmaceutical Co., Ltd. and Otsuka Pharmaceutical Development & Commercialization, Inc. announced Tuesday that an independent data monitoring committee has recommended the early termination of its Phase 3, 52-week, placebo-controlled, intramuscular depot aripiprazole trial.
FreshNews